Nccn Prostate Cancer Guidelines Reinforce Status of Myriad Genetics' Prolaris® Test as an 'advanced Tool' Recommended for Prognostic Assessment
Nccn前列腺癌指南强调万基遗传的Prolaris®测试作为推荐用于预后评估的‘爱文思控股工具’的地位
Nccn Prostate Cancer Guidelines Reinforce Status of Myriad Genetics' Prolaris® Test as an 'advanced Tool' Recommended for Prognostic Assessment
Nccn前列腺癌指南强调万基遗传的Prolaris®测试作为推荐用于预后评估的‘爱文思控股工具’的地位
译文内容由第三方软件翻译。